Validation of an In-House Assay for Cytomegalovirus Immunoglobulin G (CMV IgG) Avidity and Relationship of Avidity to CMV IgM Levels
Open Access
- 1 July 2002
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 9 (4), 824-827
- https://doi.org/10.1128/cdli.9.4.824-827.2002
Abstract
Measurement of cytomegalovirus (CMV)-specific immunoglobulin G (IgG) avidity has proven to be a powerful tool for distinguishing primary from nonprimary CMV infection. An in-house enzyme-linked immunosorbent assay (ELISA) for measuring CMV IgG avidity was validated using 84 sera from pregnant women who had recently seroconverted following primary CMV infection and 74 sera from individuals with past CMV infection (IgG-positive and IgM-negative profile). Of the 84 sera from pregnant women, 73 sera were collected within 120 days of the last IgG-negative sample, and 72 of these 73 sera (99%) exhibited an avidity index (AI) of 60%. Thus, low avidity in the in-house ELISA was defined as an AI of ⩽50%, whereas high avidity was defined as an AI of ⩾60%. In additional studies, the relationship between CMV IgG avidity and CMV IgM levels was examined using 64 CMV IgG-positive sera (time since seroconversion unknown) exhibiting equivocal or positive results in a CMV IgM capture ELISA (Diamedix). Of these 64 sera, 29 exhibited IgM index values of ⩾3.0, and 27 of these 29 (93%) exhibited low IgG avidity. A similar trend was observed when a subset of these 64 sera ( n = 48) was tested in another CMV IgM capture ELISA (Trinity); of 18 sera with IgM index values of ⩾3.0, 17 (94%) exhibited low IgG avidity. These findings demonstrate the validity of an in-house ELISA for CMV IgG avidity and further show that strong reactivity of CMV IgG-positive sera in either of two CMV IgM capture assays is a reliable indicator of low CMV IgG avidity, and thus, recent CMV infection.Keywords
This publication has 10 references indexed in Scilit:
- Ability of Three IgG-Avidity Assays to Exclude Recent Cytomegalovirus InfectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001
- Multicenter Evaluation of a Rapid and Convenient Method for Determination of Cytomegalovirus Immunoglobulin G AvidityClinical and Diagnostic Laboratory Immunology, 2001
- Evaluation of the Abbott AxSYM Cytomegalovirus (CMV) Immunoglobulin M (IgM) Assay in Conjunction with Other CMV IgM Tests and a CMV IgG Avidity AssayClinical and Diagnostic Laboratory Immunology, 2001
- Prenatal indicators of congenital cytomegalovirus infectionThe Journal of Pediatrics, 2000
- Combination of microneutralization and avidity assays: Improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancyJournal of Medical Virology, 2000
- Maternal IgG Avidity and IgM Detected by Blot as Diagnostic Tools to Identify Pregnant Women at Risk of Transmitting CytomegalovirusViral Immunology, 2000
- Delayed Acquisition of High‐Avidity Anti‐Cytomegalovirus Antibody Is Correlated with Prolonged Antigenemia in Solid Organ Transplant RecipientsThe Journal of Infectious Diseases, 1998
- Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant womenClinical and Diagnostic Virology, 1998
- Value of Cytomegalovirus (CMV) IgG Avidity Index for the Diagnosis of Primary CMV Infection in Pregnant WomenThe Journal of Infectious Diseases, 1997
- Searching for antibodies specific for human cytomegalovirus: is it diagnostically useful? When and how.1995